Daphne L Farrington Selected Research

Daphne L Farrington Research Topics

6	Neoplasms (Cancer) 12/2021 - 03/2008
2	Neutropenia 02/2017 - 12/2015
1	Carcinoma (Carcinomatosis) 12/2021
1	Embolism (Embolus) 12/2021
1	Ovarian Epithelial Carcinoma 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Mucositis 02/2017
1	Stomatitis 02/2017
1	Breast Neoplasms (Breast Cancer) 03/2016
1	Pain (Aches) 12/2015
1	Thrombocytopenia (Thrombopenia) 12/2015
1	Neoplasm Metastasis (Metastasis) 03/2008

3	p38 Mitogen-Activated Protein KinasesIBA 01/2020 - 03/2016
3	ralimetinibIBA 01/2020 - 03/2016
2	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 12/2015
1	LY3076226IBA 12/2021
1	Immunoglobulin G (IgG)IBA 12/2021
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 12/2021
1	Maytansine (Maitansine)IBA 12/2021
1	Immunoconjugates (Immunoconjugate)IBA 12/2021
1	Monoclonal AntibodiesIBA 12/2021
1	prexasertibIBA 01/2020
1	Checkpoint Kinase 1IBA 01/2020
1	Gemcitabine FDA Link 01/2020
1	PlatinumIBA 01/2020
1	pegfilgrastim (Neulasta)FDA Link 02/2017
1	litronesibIBA 02/2017
1	Hormones (Hormone)IBA 03/2016
1	Tamoxifen FDA LinkGeneric 03/2016
1	CytokinesIBA 03/2016
1	Aromatase InhibitorsIBA 03/2016
1	Pemetrexed (MTA)FDA Link 12/2015
1	Ranitidine (Zantac)FDA LinkGeneric 12/2015
1	Parathyroid Hormone-Related ProteinIBA 03/2008
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 03/2008
1	InterleukinsIBA 03/2008
1	Proteins (Proteins, Gene)FDA Link 03/2008
1	von Willebrand FactorIBA 03/2008
1	Platelet Factor 4IBA 03/2008
1	Transforming Growth Factor beta (TGF-beta)IBA 03/2008